medigraphic.com
ISSN 1025-0255 (Electronic)

2016, Number 6

<< Back Next >>

AMC 2016; 20 (6)

Rendu Osler Weber disease: one case report

Duque EL, Castro GN, Larquin CJ, Junco BMD, Betancourt RG

Language: Spanish
References: 22
Page: 735-743
PDF size: 497.48 Kb.


ABSTRACT

Background: hereditary haemorrhagic telangiectasia (HHT) or Rendu Osler Weber Sickness is a dominant autosomic illness characterized by the presence of multiple telangiectasias on skin and mucus, associated to arterovenous malformations in different organs, including lungs, central nervous system and gastrointestinal system. Its prognosis is uncertain. It is possible to improve the quality of life by diagnosing and treating it early, therefore a life expectancy similar to the general population can be reached.
Objetive: to present a case with a diagnosis of HHT.
Clinical case: A sixty-four-year-old female patient with a diagnosis of HHT 17 years ago, with episodes of frequent epistaxis and a family history of HHT (father, uncles on the father´s side and brothers) is admitted to the ICU with clinical manifestations, acute anemia and nodule lesions on her hands, fingers and auricular pavillion, with telangiectasias on the tongue.
Conclusion: HHT is not a common illness but there are cases reported all over the world.


REFERENCES

  1. Shovlin C. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010 Nov;24(6):203-19.

  2. Maune S, Schneider G. Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology. Laryngorhinootologie. 2011 Apr;90(4):230-42.

  3. Amieva M, López AC, Zamario S. Telangiectasia facial y bicitopenia como sospecha de síndrome de Rendu-Osler-Weber. Dermatología Rev Mex. 2010;54(6):342-5.

  4. McKusick. Telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber. N Engl J Med. 2011 Feb 17;364(7):688-9.

  5. Grand A. Hereditary hemorrhagic telangiectasia. Can MedAsso J. 2009;180(8):833-835.

  6. Kamath N, Bhatia S, Singh H. Hereditary Hemorrhagic Telangiectasia. North Ame J Med Sci. 2015;7(3):125-8.

  7. Pierucci P, Lenato GM, Suppressa P, Lastella P, Triggiani V, Valerio R, et al. A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study. Orphanet J Rare Dis. 2012 Jun 7;7:33.

  8. Govani F, Shovlin C . Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J HumGenet. 2009;17(7):860-71.

  9. Yin L, Reh D, Hoag J, Robinson G. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia. The Laryngoscope. a clinical and scientific review. Eur J Hum Genet. 2015;171(4):443-52.

  10. Dittus C, Streiff M, Ansell J. Bleeding and clotting in hereditary hemorrhagic telangiectasia. Wor J Clin Cas. 2015;3(4):330-7.

  11. Geisthoff U, Nguyen H, Röth A. How to manage patients with hereditary haemorrhagic telangiectasia. Br J Haematol. 2015;171(4):443-52.

  12. Stapf C, Mohr J. Unruptured brain arteriovenous malformations should be treated conservativelyyes. Stroke. 2007;38(12):3308-9.

  13. Neetika G, Khunger M, Gupta A. Optimal management of hereditary hemorrhagictelangiectasia. J Blood Med. 2014;5(1):191-206.

  14. Buonamico P, Suppressa P, Lenato G. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color- Doppler vs multislice computed tomography study. J Hepatol. 2008;8(5):811-20.

  15. Wain K, Ellingson M, McDonald J, Gammon A, Roberts M, Pichurin P, et al. Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med. 2014;16(8):588-93.

  16. Livesey J, Manning R, Meek J. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia. Thorax. 2013;67(4):328-33.

  17. Hosman A, Devlin H, Silva B. Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls. Orphanet J Rare Dis. 2013;20(8):195.

  18. González R, Trapero M, & Moreno R. Hepatic disease in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Med Clin (Barc). 2007;129(16):629-31.

  19. Faughnan M, Palda V, Garcia G. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2014;48(2):73-87.

  20. Nollen GJ, Kodde J, Beek AM, JMJ Res. Van Rossu AC. Quadricuspid pulmonary valve and left pulmonary artery aneurysm in an asymptomatic patient assessed by cardiovascular MRI. Neth Heart J 2013;21:196-8.

  21. Rao U, Nair SK, Agarwal A. Aneurysm of pulmonary artery. Heart 2013;98(22):1684.

  22. Peery W. Clinical Spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1987;82:989-97.




2020     |     www.medigraphic.com